Mortality hazard ratio was 1.64 in association with infection with VOC-202012\/1 versus infection with previously circulating variants <\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, March 16, 2021 (HealthDay News) — The risk for mortality is increased in association with infection with a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) designated a variant of concern (VOC-202012\/1) in December 2020, according to a study published online March 10 in The BMJ<\/em>.<\/p>\n Robert Challen, Ph.D., from the University of Exeter in the United Kingdom, and colleagues conducted a cohort study involving 54,906 matched pairs of participants who tested positive for SARS-CoV-2 in community-based COVID-19 testing centers between Oct. 1, 2020, and Jan. 29, 2021. Participants differed only on detectability of the spike protein gene using the TaqPath assay (a proxy measure of VOC-202012\/1 infection).<\/p>\n The researchers found that for patients who tested positive for COVID-19 in the community, the mortality hazard ratio associated with infection with VOC-202012\/1 compared with infection with previously circulating variants was 1.64. This represented an increase in deaths from 2.5 to 4.1 per 1,000 detected cases in this relatively low-risk group.<\/p>\n “In the community, death from COVID-19 is still a rare event, but the B.1.1.7 variant raises the risk,” Challen said in a statement. “Coupled with its ability to spread rapidly this makes B.1.1.7 a threat that should be taken seriously.”<\/p>\n